Literature DB >> 10908893

Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.

K Kantarci1, C R Jack, Y C Xu, N G Campeau, P C O'Brien, G E Smith, R J Ivnik, B F Boeve, E Kokmen, E G Tangalos, R C Petersen.   

Abstract

BACKGROUND: Mild cognitive impairment (MCI) is a recently described transitional clinical state between normal aging and AD. Assuming that amnestic MCI patients had pathologic changes corresponding to an early phase and probable AD patients to a later phase of the disease progression, the authors could approximate the temporal course of proton MR spectroscopic (1H MRS) alterations in AD with a cross-sectional sampling scheme.
METHODS: The authors compared 1H MRS findings in the superior temporal lobe, posterior cingulate gyri, and medial occipital lobe in 21 patients with MCI, 21 patients with probable AD, and 63 elderly controls. These areas are known to be involved at different neurofibrillary pathologic stages of AD.
RESULTS: The N-acetylaspartate (NAA)/creatine (Cr) ratios were significantly lower in AD patients compared to both MCI and normal control subjects in the left superior temporal and the posterior cingulate volumes of interest (VOI) and there were no between-group differences in the medial occipital VOI. Myoinositol (MI)/Cr ratios measured from the posterior cingulate VOI were significantly higher in both MCI and AD patients than controls. The choline (Cho)/Cr ratios measured from the posterior cingulate VOI were higher in AD patients compared to both MCI and control subjects.
CONCLUSION: These findings suggest that the initial 1H MRS change in the pathologic progression of AD is an increase in MI/Cr. A decrease in NAA/Cr and an increase in Cho/Cr develop later in the disease course.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908893      PMCID: PMC2771162          DOI: 10.1212/wnl.55.2.210

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

1.  Automated single-voxel proton MRS: technical development and multisite verification.

Authors:  P G Webb; N Sailasuta; S J Kohler; T Raidy; R A Moats; R E Hurd
Journal:  Magn Reson Med       Date:  1994-04       Impact factor: 4.668

2.  Brief report: organic osmolytes in the brain of an infant with hypernatremia.

Authors:  J H Lee; E Arcinue; B D Ross
Journal:  N Engl J Med       Date:  1994-08-18       Impact factor: 91.245

3.  Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.

Authors:  D J Meyerhoff; S MacKay; J M Constans; D Norman; C Van Dyke; G Fein; M W Weiner
Journal:  Ann Neurol       Date:  1994-07       Impact factor: 10.422

4.  Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.

Authors:  R C Petersen; G E Smith; R J Ivnik; E G Tangalos; D J Schaid; S N Thibodeau; E Kokmen; S C Waring; L T Kurland
Journal:  JAMA       Date:  1995-04-26       Impact factor: 56.272

5.  Memory function in very early Alzheimer's disease.

Authors:  R C Petersen; G E Smith; R J Ivnik; E Kokmen; E G Tangalos
Journal:  Neurology       Date:  1994-05       Impact factor: 9.910

6.  Probable Alzheimer disease: diagnosis with proton MR spectroscopy.

Authors:  T K Shonk; R A Moats; P Gifford; T Michaelis; J C Mandigo; J Izumi; B D Ross
Journal:  Radiology       Date:  1995-04       Impact factor: 11.105

7.  Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging.

Authors:  S MacKay; F Ezekiel; V Di Sclafani; D J Meyerhoff; J Gerson; D Norman; G Fein; M W Weiner
Journal:  Radiology       Date:  1996-02       Impact factor: 11.105

Review 8.  N-acetylaspartate in neuropsychiatric disorders.

Authors:  G Tsai; J T Coyle
Journal:  Prog Neurobiol       Date:  1995-08       Impact factor: 11.685

9.  Role of increased cerebral myo-inositol in the dementia of Down syndrome.

Authors:  T Shonk; B D Ross
Journal:  Magn Reson Med       Date:  1995-06       Impact factor: 4.668

10.  Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study.

Authors:  J S Videen; T Michaelis; P Pinto; B D Ross
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more
  149 in total

Review 1.  Neuroimaging and behavior: probing brain behavior relationships in the 21st century.

Authors:  J Mandzia; S E Black
Journal:  Curr Neurol Neurosci Rep       Date:  2001-11       Impact factor: 5.081

2.  Mild cognitive impairment and Alzheimer disease: regional diffusivity of water.

Authors:  K Kantarci; C R Jack; Y C Xu; N G Campeau; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; E Kokmen; E G Tangalos; R C Petersen
Journal:  Radiology       Date:  2001-04       Impact factor: 11.105

3.  Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.

Authors:  Alexander P Lin; Frederick Shic; Cathleen Enriquez; Brian D Ross
Journal:  MAGMA       Date:  2003-02       Impact factor: 2.310

4.  Brain metabolic correlates of decision making in amnestic mild cognitive impairment.

Authors:  H Randall Griffith; Ozioma C Okonkwo; Jan A den Hollander; Katherine Belue; Jacqueline Copeland; Lindy E Harrell; John C Brockington; David G Clark; Daniel C Marson
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2010-04-06

5.  [MR spectroscopy in dementia].

Authors:  T Hauser; L Gerigk; F Giesel; L Schuster; M Essig
Journal:  Radiologe       Date:  2010-09       Impact factor: 0.635

6.  Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.

Authors:  Paul G Unschuld; Richard A E Edden; Aaron Carass; Xinyang Liu; Megan Shanahan; Xin Wang; Kenichi Oishi; Jason Brandt; Susan S Bassett; Graham W Redgrave; Russell L Margolis; Peter C M van Zijl; Peter B Barker; Christopher A Ross
Journal:  Mov Disord       Date:  2012-05-30       Impact factor: 10.338

7.  Prediction of conversion from mild cognitive impairment to Alzheimer disease based on bayesian data mining with ensemble learning.

Authors:  R Chen; K Young; L L Chao; B Miller; K Yaffe; M W Weiner; E H Herskovits
Journal:  Neuroradiol J       Date:  2012-03-01

Review 8.  Emerging biomarkers in cognition.

Authors:  Meredith Wicklund; Ronald C Petersen
Journal:  Clin Geriatr Med       Date:  2013-11       Impact factor: 3.076

Review 9.  Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia.

Authors:  Howard Chertkow; Fadi Massoud; Ziad Nasreddine; Sylvie Belleville; Yves Joanette; Christian Bocti; Valérie Drolet; John Kirk; Morris Freedman; Howard Bergman
Journal:  CMAJ       Date:  2008-05-06       Impact factor: 8.262

10.  Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements.

Authors:  Kejal Kantarci; David S Knopman; Dennis W Dickson; Joseph E Parisi; Jennifer L Whitwell; Stephen D Weigand; Keith A Josephs; Bradley F Boeve; Ronald C Petersen; Clifford R Jack
Journal:  Radiology       Date:  2008-07       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.